Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy. (Q64932628)
Jump to navigation
Jump to search
scientific article published in December 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy. |
scientific article published in December 1998 |
Statements
Effect of oral acyclovir or ganciclovir therapy after preemptive intravenous ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus seropositive renal and liver transplant recipients receiving antilymphocyte antibody therapy. (English)
Turgeon N
Fishman JA
Basgoz N
Tolkoff-Rubin NE
Doran M
Cosimi AB
Rubin RH
1 December 1998
66
12
1780-1786